SURGERY PARTNERS INC (SGRY) Forecast, Price Target & Analyst Ratings

NASDAQ:SGRY • US86881A1007

Current stock price

12.94 USD
+0.29 (+2.29%)
At close:
12.8 USD
-0.14 (-1.08%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SURGERY PARTNERS INC (SGRY).

Forecast Snapshot

Consensus Price Target

Price Target
$19.73
+ 52.46% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.12
Revenue Estimate
813.85M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.11%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$19.73
Upside
+ 52.46%
From current price of $12.94 to mean target of $19.73, Based on 18 analyst forecasts
Low
$14.14
Median
$20.40
High
$26.25

Price Target Revisions

1 Month
-24.02%
3 Months
-25.61%

Price Target Summary

18 Wall Street analysts provided a forecast for the next 12 months for SGRY. The average price target is 19.73 USD. This implies a price increase of 52.46% is expected in the next year compared to the current price of 12.94.
The average price target has been revised downward by 25.61% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SGRY Current Analyst RatingSGRY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

SGRY Historical Analyst RatingsSGRY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
81.11%
SGRY was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about SGRY.
In the previous month the buy percentage consensus was at a similar level.
SGRY was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05TD CowenMaintains Buy -> Buy
2026-03-05MizuhoMaintains Outperform -> Outperform
2026-03-05UBSMaintains Buy -> Buy
2026-03-04RBC CapitalMaintains Outperform -> Outperform
2026-03-03BarclaysMaintains Equal-Weight -> Equal-Weight
2025-12-18MizuhoMaintains Outperform -> Outperform
2025-11-24JP MorganMaintains Neutral -> Neutral
2025-11-21BarclaysMaintains Equal-Weight -> Equal-Weight
2025-11-17MizuhoMaintains Outperform -> Outperform
2025-11-13UBSMaintains Buy -> Buy
2025-11-11RBC CapitalMaintains Outperform -> Outperform
2025-11-11BenchmarkMaintains Buy -> Buy
2025-10-07Cantor FitzgeraldReiterate Overweight -> Overweight
2025-05-27BarclaysMaintains Equal-Weight -> Equal-Weight
2025-04-21BenchmarkReiterate Buy -> Buy
2025-03-25RBC CapitalReiterate Outperform -> Outperform
2025-03-11MacquarieMaintains Outperform -> Outperform
2024-12-03JP MorganMaintains Neutral -> Neutral
2024-11-20RBC CapitalMaintains Outperform -> Outperform
2024-11-19MacquarieMaintains Outperform -> Outperform
2024-11-13MacquarieMaintains Outperform -> Outperform
2024-11-04MacquarieMaintains Outperform -> Outperform
2024-10-14UBSInitiate Buy
2024-10-11KeybancInitiate Sector Weight
2024-10-04Cantor FitzgeraldReiterate Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.12
Revenue Estimate
813.85M
Revenue Q2Q
4.88%
EPS Q2Q
-393.25%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
-2.91%
Revenue (3 Months)
-2.91%
EPS (1 Month)
-519.28%
EPS (3 Months)
-519.28%

Next Earnings Summary

SGRY is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.12 USD and the consensus revenue estimate is 813.85M USD.
The next earnings revenue estimate has been revised downward by 2.91% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
SGRY revenue by date.SGRY revenue by date.
2.743B
8.03%		3.114B
13.52%		3.309B
6.24%		3.477B
5.09%		3.674B
5.67%		3.987B
8.52%		4.589B
15.10%
EBITDA
YoY % growth
SGRY ebitda by date.SGRY ebitda by date.
533M
8.93%		626.9M
17.62%		655.5M
4.56%		596.46M
-9.01%		658.23M
10.36%		696.66M
5.84%		N/A
EBIT
YoY % growth
SGRY ebit by date.SGRY ebit by date.
414.9M
10.79%		474.3M
14.32%		479.5M
1.10%		445.58M
-7.07%		495.11M
11.12%		451.91M
-8.73%		N/A
Operating Margin
SGRY operating margin by date.SGRY operating margin by date.
15.12%15.23%14.49%12.82%13.48%11.33%N/A
EPS
YoY % growth
SGRY eps by date.SGRY eps by date.
0.99
661.54%		0.94
-5.05%		0.46
-51.06%		0.75
62.98%		0.97
28.91%		1.34
38.26%		1.72
29.01%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.12
-393.25%		0.04
-74.00%		0.08
-35.92%		0.23
92.67%		-0.05
58.70%		0.13
203.88%		0.16
91.83%		0.34
45.59%		-0.02
57.89%		0.19
44.30%		0.16
2.13%		0.38
12.12%
Revenue
Q2Q % growth		813.85M
4.88%		861.96M
4.33%		867.73M
5.63%		933.7M
5.50%		857.07M
5.31%		914.03M
6.04%		920.44M
6.07%		1.001B
7.21%		875.16M
2.11%		936.36M
2.44%		928.2M
0.84%		1.024B
2.30%
EBITDA
Q2Q % growth		102.8M
-18.35%		131.7M
-33.45%		140.32M
-44.14%		167.5M
-45.88%		112.1M
9.05%		144.24M
9.52%		150.4M
7.18%		182.11M
8.72%		121.99M
8.82%		154.84M
7.35%		151.78M
0.92%		183.5M
0.76%
EBIT
Q2Q % growth		75.534M
-15.70%		108.87M
-10.25%		117.6M
-12.95%		142.77M
6.94%		86.59M
14.64%		121.15M
11.28%		129.69M
10.28%		162M
13.47%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SGRY Yearly Revenue VS EstimatesSGRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
SGRY Yearly EPS VS EstimatesSGRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 -1 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
42.68%
EPS Next 5 Year
39.13%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
5.91%
Revenue Next 5 Year
8.14%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
18.21%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SURGERY PARTNERS INC / SGRY Forecast FAQ

What do analysts expect the price target to be for SURGERY PARTNERS INC (SGRY)?

18 analysts have analysed SGRY and the average price target is 19.73 USD. This implies a price increase of 52.46% is expected in the next year compared to the current price of 12.94.

What is the next earnings date for SGRY stock?

SURGERY PARTNERS INC (SGRY) will report earnings on 2026-05-11, before the market open.

Can you provide the consensus estimates for SURGERY PARTNERS INC next earnings?

The consensus EPS estimate for the next earnings of SURGERY PARTNERS INC (SGRY) is -0.12 USD and the consensus revenue estimate is 813.85M USD.

What is the number of analysts for SGRY stock?

The number of analysts covering SURGERY PARTNERS INC (SGRY) is 18.